RECQL and ovarian cancer: Indeed, overexpression of RECQ1 has been experimentally demonstrated in human glioblastoma (Mendoza-Maldonado et al., 2011), ovarian cancer (Sanada et al., 2013), and head and neck squamous cell carcinoma (Arai et al., 2011).